Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody-Drug Conjugate, Shows Antitumor Activity in Uterine Serous Carcinoma with HER2/Neu Expression.
Mol Cancer Ther. 2016 Aug;15(8):1900-9. doi: 10.1158/1535-7163.MCT-16-0163. Epub 2016 Jun 2.
Mol Cancer Ther. 2016.
PMID: 27256376
The Preclinical Profile of the Duocarmycin-Based HER2-Targeting ADC SYD985 Predicts for Clinical Benefit in Low HER2-Expressing Breast Cancers.
van der Lee MM, Groothuis PG, Ubink R, van der Vleuten MA, van Achterberg TA, Loosveld EM, Damming D, Jacobs DC, Rouwette M, Egging DF, van den Dobbelsteen D, Beusker PH, Goedings P, Verheijden GF, Lemmens JM, Timmers M, Dokter WH.
van der Lee MM, et al. Among authors: goedings p.
Mol Cancer Ther. 2015 Mar;14(3):692-703. doi: 10.1158/1535-7163.MCT-14-0881-T. Epub 2015 Jan 14.
Mol Cancer Ther. 2015.
PMID: 25589493
Item in Clipboard
(E,E)-alpha-farnesene the main substance of the volatiles of the flowers from European mistletoe (Viscum album L.).
Bungert M, Thiel R, Goedings P, Becker H.
Bungert M, et al. Among authors: goedings p.
Z Naturforsch C J Biosci. 2002 Jan-Feb;57(1-2):205-7. doi: 10.1515/znc-2002-1-233.
Z Naturforsch C J Biosci. 2002.
PMID: 11926536
Free article.
Item in Clipboard
Cite
Cite